Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > CR at 450

<< Previous

Bullboard Posts

Next >>

Comment by Longholder99on Jul 25, 2022 11:47am

168 Views

Post# 34848218

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CR at 450

Sadly covid isnt going anywhere. I know as I just got through a bout of it with this new variant and its no picnic. What doesn't kill you, mutates and tries to kill you again is basically the way its going to be unless something changes. If Theralase has a non immuno and therefore novel non variant dependant approach to neutralizing covid the markets may totally walk this up. It may have a bigger effect on SP than BTD for NMIBC.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”